147 related articles for article (PubMed ID: 32916011)
1. Monoacylglycerol Acyltransferase 1 Knockdown Exacerbates Hepatic Ischemia/Reperfusion Injury in Mice With Hepatic Steatosis.
Liss KHH; Ek SE; Lutkewitte AJ; Pietka TA; He M; Skaria P; Tycksen E; Ferguson D; Blanc V; Graham MJ; Hall AM; McGill MR; McCommis KS; Finck BN
Liver Transpl; 2021 Jan; 27(1):116-133. PubMed ID: 32916011
[TBL] [Abstract][Full Text] [Related]
2. Multiple antisense oligonucleotides targeted against monoacylglycerol acyltransferase 1 (Mogat1) improve glucose metabolism independently of Mogat1.
Lutkewitte AJ; Singer JM; Shew TM; Martino MR; Hall AM; He M; Finck BN
Mol Metab; 2021 Jul; 49():101204. PubMed ID: 33676028
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting monoacylglycerol acyltransferase 1 ameliorates hepatic metabolic abnormalities but not inflammation and injury in mice.
Soufi N; Hall AM; Chen Z; Yoshino J; Collier SL; Mathews JC; Brunt EM; Albert CJ; Graham MJ; Ford DA; Finck BN
J Biol Chem; 2014 Oct; 289(43):30177-88. PubMed ID: 25213859
[TBL] [Abstract][Full Text] [Related]
4. Abrogating monoacylglycerol acyltransferase activity in liver improves glucose tolerance and hepatic insulin signaling in obese mice.
Hall AM; Soufi N; Chambers KT; Chen Z; Schweitzer GG; McCommis KS; Erion DM; Graham MJ; Su X; Finck BN
Diabetes; 2014 Jul; 63(7):2284-96. PubMed ID: 24595352
[TBL] [Abstract][Full Text] [Related]
5. The impact of diet-induced hepatic steatosis in a murine model of hepatic ischemia/reperfusion injury.
Liss KHH; McCommis KS; Chambers KT; Pietka TA; Schweitzer GG; Park SL; Nalbantoglu I; Weinheimer CJ; Hall AM; Finck BN
Liver Transpl; 2018 Jul; 24(7):908-921. PubMed ID: 29729104
[TBL] [Abstract][Full Text] [Related]
6. Dynamic changes in the mouse hepatic lipidome following warm ischemia reperfusion injury.
Liss KHH; Mousa M; Bucha S; Lutkewitte A; Allegood J; Cowart LA; Finck BN
Sci Rep; 2024 Feb; 14(1):3584. PubMed ID: 38351300
[TBL] [Abstract][Full Text] [Related]
7. Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice.
Kato H; Duarte S; Miller MG; Busuttil RW; Coito AJ
Liver Transpl; 2019 Feb; 25(2):288-301. PubMed ID: 30358115
[TBL] [Abstract][Full Text] [Related]
8. Mogat1 deletion does not ameliorate hepatic steatosis in lipodystrophic (Agpat2-/-) or obese (ob/ob) mice.
Agarwal AK; Tunison K; Dalal JS; Yen CL; Farese RV; Horton JD; Garg A
J Lipid Res; 2016 Apr; 57(4):616-30. PubMed ID: 26880786
[TBL] [Abstract][Full Text] [Related]
9. Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver.
Hall AM; Kou K; Chen Z; Pietka TA; Kumar M; Korenblat KM; Lee K; Ahn K; Fabbrini E; Klein S; Goodwin B; Finck BN
J Lipid Res; 2012 May; 53(5):990-999. PubMed ID: 22394502
[TBL] [Abstract][Full Text] [Related]
10. TLR4 knockout upregulates the expression of Mfn2 and PGC-1α in a high-fat diet and ischemia-reperfusion mice model of liver injury.
Zhang C; Jia Y; Liu B; Wang G; Zhang Y
Life Sci; 2020 Aug; 254():117762. PubMed ID: 32437795
[TBL] [Abstract][Full Text] [Related]
11. A role for complement in the enhanced susceptibility of steatotic livers to ischemia and reperfusion injury.
He S; Atkinson C; Evans Z; Ellett JD; Southwood M; Elvington A; Chavin KD; Tomlinson S
J Immunol; 2009 Oct; 183(7):4764-72. PubMed ID: 19752222
[TBL] [Abstract][Full Text] [Related]
12. MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury.
Kato H; Kuriyama N; Duarte S; Clavien PA; Busuttil RW; Coito AJ
J Hepatol; 2014 May; 60(5):1032-9. PubMed ID: 24412604
[TBL] [Abstract][Full Text] [Related]
13. Hepatic monoacylglycerol acyltransferase 1 is induced by prolonged food deprivation to modulate the hepatic fasting response.
Lutkewitte AJ; McCommis KS; Schweitzer GG; Chambers KT; Graham MJ; Wang L; Patti GJ; Hall AM; Finck BN
J Lipid Res; 2019 Mar; 60(3):528-538. PubMed ID: 30610082
[TBL] [Abstract][Full Text] [Related]
14. Steatotic livers are susceptible to normothermic ischemia-reperfusion injury from mitochondrial Complex-I dysfunction.
Chu MJ; Premkumar R; Hickey AJ; Jiang Y; Delahunt B; Phillips AR; Bartlett AS
World J Gastroenterol; 2016 May; 22(19):4673-84. PubMed ID: 27217699
[TBL] [Abstract][Full Text] [Related]
15. Oral N-acetylcysteine decreases IFN-γ production and ameliorates ischemia-reperfusion injury in steatotic livers.
Liggett JR; Kang J; Ranjit S; Rodriguez O; Loh K; Patil D; Cui Y; Duttargi A; Nguyen S; He B; Lee Y; Oza K; Frank BS; Kwon D; Li HH; Kallakury B; Libby A; Levi M; Robson SC; Fishbein TM; Cui W; Albanese C; Khan K; Kroemer A
Front Immunol; 2022; 13():898799. PubMed ID: 36148239
[TBL] [Abstract][Full Text] [Related]
16. Mitigation of autophagy ameliorates hepatocellular damage following ischemia-reperfusion injury in murine steatotic liver.
Gupta NA; Kolachala VL; Jiang R; Abramowsky C; Shenoi A; Kosters A; Pavuluri H; Anania F; Kirk AD
Am J Physiol Gastrointest Liver Physiol; 2014 Dec; 307(11):G1088-99. PubMed ID: 25258410
[TBL] [Abstract][Full Text] [Related]
17. BH3-only proteins contribute to steatotic liver ischemia-reperfusion injury.
DuBray BJ; Conzen KD; Upadhya GA; Gunter KL; Jia J; Knolhoff BL; Mohanakumar T; Chapman WC; Anderson CD
J Surg Res; 2015 Apr; 194(2):653-658. PubMed ID: 25483735
[TBL] [Abstract][Full Text] [Related]
18. The inhibition of aldose reductase attenuates hepatic ischemia-reperfusion injury through reducing inflammatory response.
Li CX; Ng KT; Shao Y; Liu XB; Ling CC; Ma YY; Geng W; Qi X; Cheng Q; Chung SK; Lo CM; Man K
Ann Surg; 2014 Aug; 260(2):317-28. PubMed ID: 24699020
[TBL] [Abstract][Full Text] [Related]
19. Type 1 Innate Lymphoid Cells Are Proinflammatory Effector Cells in Ischemia-Reperfusion Injury of Steatotic Livers.
Kang J; Liggett JR; Patil D; Ranjit S; Loh K; Duttargi A; Cui Y; Oza K; Frank BS; Kwon D; Kallakury B; Robson SC; Fishbein TM; Cui W; Khan K; Kroemer A
Front Immunol; 2022; 13():899525. PubMed ID: 35833123
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial bioenergetics boost macrophage activation, promoting liver regeneration in metabolically compromised animals.
Goikoetxea-Usandizaga N; Serrano-Maciá M; Delgado TC; Simón J; Fernández Ramos D; Barriales D; Cornide ME; Jiménez M; Pérez-Redondo M; Lachiondo-Ortega S; Rodríguez-Agudo R; Bizkarguenaga M; Zalamea JD; Pasco ST; Caballero-Díaz D; Alfano B; Bravo M; González-Recio I; Mercado-Gómez M; Gil-Pitarch C; Mabe J; Gracia-Sancho J; Abecia L; Lorenzo Ó; Martín-Sanz P; Abrescia NGA; Sabio G; Rincón M; Anguita J; Miñambres E; Martín C; Berenguer M; Fabregat I; Casado M; Peralta C; Varela-Rey M; Martínez-Chantar ML
Hepatology; 2022 Mar; 75(3):550-566. PubMed ID: 34510498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
